AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Jan 21, 2021
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The AIM's Writing for Healing workshop is a clinical trial designed to help adults living with paralysis from neurological conditions, such as spinal cord injuries, multiple sclerosis, and amyotrophic lateral sclerosis (ALS). This program focuses on using expressive writing as a way to cope with emotional challenges and improve overall well-being. The trial is currently recruiting participants aged 18 and older who have experienced paralysis due to a traumatic event or neurological disease, as well as caregivers of individuals with ALS.
Participants can expect to join writing workshops that provide a supportive space to share their experiences and feelings. To be eligible, individuals must be able to communicate verbally or through writing and meet certain criteria regarding their paralysis. However, those with specific behavioral issues or congenital conditions will not be included in the study. This trial offers a unique opportunity for individuals facing paralysis to explore their emotions and connect with others in similar situations through the power of writing.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 18 or older with paralysis living in the community
- • 2. limb paralysis resulting from a traumatic event/accident or neurological disease (e.g., spinal cord injury, head injury, stroke, multiple sclerosis, Transverse myelitis, poliomyelitis, peripheral neuropathy, Parkinson's disease, ALS, botulism, and Guillain-Barré syndrome etc) happened after childhood
- • 3. a non-traumatic spinal cord injury may be caused by arthritis, cancer, inflammation, infections or disk degeneration of the spine
- • 4. caregivers of people with amyotrophic lateral sclerosis
- • 5. able to communicate verbally or through writing
- Exclusion Criteria:
- • 1. known maladaptive behavioral patterns, exhibition of overt psychotic symptoms (e.g., presence of hallucinations, delusions, or thought disorders)
- • 2. congenital (e.g., spinal bifida, cerebral palsy)
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials